Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wilson (Southampton, United Kingdom), A. Faruqi (San Francisco, United States of America), J. Ward (Southampton, United Kingdom), J. Norman (Southampton, United Kingdom), A. Sousa (Stevenage, United Kingdom), J. Corfield (Nottingham, United Kingdom), P. Sterk (Amsterdam, Netherlands), F. Chung (London, United Kingdom), R. Djukanovic (Southampton, United Kingdom), B. Dahlen (Stockholm, Sweden), P. Chanez (Marseille, France), D. Shaw (Nottingham, United Kingdom), N. Krug (Hannover, Germany), T. Sandstrom (Umea, Sweden), P. Howarth (Southampton, United Kingdom), C. Holweg (San Francisco, United States of America). Periostin expression in the U-BIOPRED severe asthma bronchoscopy cohort. 951

Member's Comments

No comment yet.

Related content which might interest you: Airway remodelling in the U-BIOPRED severe asthma cohort Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Periostin as a marker of remodeling in young adults with clinical remission of asthma Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Serum periostin but not airway POSTN expression is reduced in smokers with asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Osteopontin expression and relation to disease severity in human asthma Source: Eur Respir J 2011; 37: 331 Year: 2011 Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects Source: International Congress 2016 – Mechanisms of disease Year: 2016 Espression of clusterin and CD44 in bronchial biopsies of subjects with asthma and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 321s Year: 2004 Periostin and TSLP: New markers useful in diagnosis of obstructive lung disease Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Serum periostin in healthy controls and patients with asthma and chronic rhinosinusitis; data from the Swedish GA(2)LEN population study Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Bronchoscopic evaluation of the lower airways in patients with persistent severe asthma Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques Year: 2015 Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden Source: Eur Respir J 2002; 19: 127-133 Year: 2002 Radiologic assed rhinosinusitis, eosinophils and lung function in a population-based cohort of elderly, a comparison of subjects with and without asthma Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Asthma symptom control, biomarkers of airway inflammation and spirometry in a cohort of Sri Lankan children Source: Virtual Congress 2020 – Paediatric asthma Year: 2020 Osteopontin and periostin in bronchial tissue associate with a 20-year decline of pulmonary function in asthmatics Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Patterns of airway disease and the clinical diagnosis of asthma in the Busselton population Source: Eur Respir J 2011; 38: 1053-1059 Year: 2011 Gene expression in bronchial biopsies from subjects with persistent asthma and asthma in remission Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Use of expression microarrays in studies of asthma, acute lung injury and emphysema Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Assessment of cytokine mRNA expression in patients with COPD exacerbations Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology. Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021